Key result
Vigorous treatment of neuroleptic malignant syndrome following cessation of fluphenazine decanoate led to recovery and sustained improvement in mental state and social functioning.
Population
29-year-old man diagnosed with neuroleptic malignant syndrome after being on fluphenazine decanoate for over…
Design
Case_report
Follow-up
over three months
Authors
Loading...
Hypothesis-generating for vigorous NMS treatment after long-acting antipsychotics; prospective studies needed before practice change.
Case Report (n=1)
Highlights the need for vigilance in detecting NMS after prolonged neuroleptic exposure and demonstrates potential for significant psychiatric improvement post-recovery.
Gavin Cape (1994) conducted a case report in Neuroleptic malignant syndrome (n=1). Fluphenazine decanoate cessation was evaluated on Recovery and mental state improvement. Vigorous treatment of neuroleptic malignant syndrome following cessation of fluphenazine decanoate led to recovery and sustained improvement in mental state and social functioning.